fenofibrate has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, MS | 1 |
| Han, QS | 1 |
| Jia, ZR | 1 |
| Chen, CS | 1 |
| Qiao, C | 1 |
| Liu, QQ | 1 |
| Zhang, YM | 1 |
| Wang, KW | 1 |
| Wang, J | 1 |
| Xiao, K | 1 |
| Ding, XS | 1 |
| Goncalves, MD | 1 |
| Hwang, SK | 1 |
| Pauli, C | 1 |
| Murphy, CJ | 1 |
| Cheng, Z | 1 |
| Hopkins, BD | 1 |
| Wu, D | 1 |
| Loughran, RM | 1 |
| Emerling, BM | 1 |
| Zhang, G | 1 |
| Fearon, DT | 1 |
| Cantley, LC | 1 |
2 other studies available for fenofibrate and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
PPARĪ± agonist fenofibrate relieves acquired resistance to gefitinib in non-small cell lung cancer by promoting apoptosis via PPARĪ±/AMPK/AKT/FoxO1 pathway.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cel | 2022 |
Fenofibrate prevents skeletal muscle loss in mice with lung cancer.
Topics: Amino Acids; Animals; Cachexia; Carcinoma, Non-Small-Cell Lung; Drug Evaluation, Preclinical; Fenofi | 2018 |